Japan to require post-marketing studies for genetic tests
This article was originally published in Clinica
Executive Summary
A Japanese Ministry of Health and Welfare committee has proposed requiring manufacturers of new genetic tests to conduct post-marketing surveillance (PMS) studies with their products. Companies would be expected to report the results as quickly as possible to hospitals and laboratory test centres, reports Pharma Japan.